In a case concerning Rajasthani, the court held that children cannot be denied education in a language they understand, and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akamis Bio, a clinical-stage oncology company working to advance the standard of care in colorectal cancer, today announced early data from the on-going Phase 1b ...
The trial will enrol 30 adults with pMMR LARC, administering NG-350A plus CRT over 12 weeks. Credit: Catalin Rusnac / Shutterstock.com. Akamis Bio has announced encouraging initial findings from its ...
Digital Grid Corp is engaged in trading platforms for electric power and environmental value. Its services include D.G.P a Power procurement and trading platform, Econoha Environmental value ...
WENZHOU, ZHEJIANG, CHINA, April 3, 2026 /EINPresswire.com/ — The world’s lightest 350A industrial inverter – fits where no welder has gone before. One Machine ...
Kioti surprised attendees at this year’s ConExpo by dropping the curtain — literally — on three of its first-ever mini excavators. A crowd gathered on Day 1 of the show as Kioti unveiled its new MX ...
Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026 Company to disclose clinical safety and ...
Company to disclose clinical safety and efficacy data for NG-350A in combination with chemoradiotherapy following 12-week active treatment period CAMBRIDGE, Mass., March 17, 2026--(BUSINESS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results